EGFR-BAT
Showing 1 - 25 of 1,929
Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville
Active, not recruiting
- Pancreatic Cancer
- +3 more
- anti-EGFR-bispecific antibody armed activated T-cells
-
New York, New York
- +1 more
Oct 7, 2021
Non-squamous NSCLC, EGFR Gene Mutation Trial in Chengdu (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)
Not yet recruiting
- Non-squamous Non-small Cell Lung Cancer
- EGFR Gene Mutation
- Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed
-
Chengdu, Sichuan, China
- +2 more
May 24, 2022
Carcinogenesis-related Molecular Markers in Colon Cancer and
Active, not recruiting
- Colorectal Cancer
- Colorectal Adenoma
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Nov 27, 2022
Cancer, Lung, Cancer of Esophagus, Cancer of Head and Neck Trial in Hualien City
Recruiting
- Cancer, Lung
- +2 more
-
Hualien City, TaiwanHualien Tzu Chi Hospital
Sep 12, 2022
Brown Adipose Tissue, Metabolic Disease Trial in Basel (Carbohydrate, Fat, Protein)
Not yet recruiting
- Brown Adipose Tissue
- Metabolic Disease
- Carbohydrate
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Dept. of Endocrinology
Oct 5, 2023
Inuit and Cold Exposure
Recruiting
- Healthy
- Short-term cold exposure
-
Aalborg, DenmarkAalborg University Hospital
May 22, 2023
Obesity Trial in Nice (Sampling)
Not yet recruiting
- Obesity
- Sampling
-
Nice, FranceHôpital Archet 2
Apr 25, 2023
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Botulism Trial (A minimum of one 5 mL serum sample (up to three per enrolled subject) will be collected.)
Enrolling by invitation
- Botulism
- Blood sample collection
- (no location specified)
Jan 30, 2023
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
Fibromyalgia Trial in Gainesville (Breathing and Attention Training (BAT), Breathing Control)
Recruiting
- Fibromyalgia
- Breathing and Attention Training (BAT)
- Breathing Control
-
Gainesville, FloridaUniversity of Florida
Mar 23, 2023
Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)
Recruiting
- Pheochromocytoma
- Paraganglioma
- Infrared themrography
-
Marseille, Paca, FrancePôle ENDO- Hopital la Conception APHM
Nov 12, 2022
Obesity Trial in Turku (Cold acclimation, Intervention Control group - volunteers with obesity, Acute cold exposure)
Not yet recruiting
- Obesity
- Cold acclimation
- +2 more
-
Turku, FinlandTurku PET Centre
Jul 19, 2022
Chronic Low-back Pain Trial in Gainesville (Breathing and Attention Training)
Recruiting
- Chronic Low-back Pain
- Breathing and Attention Training
-
Gainesville, FloridaUniversity of Florida
May 25, 2022
Food Allergy, Food Allergy in Infants, Food Allergy in Children Trial in United Kingdom (Basophil activation test (BAT), Oral
Not yet recruiting
- Food Allergy
- +6 more
- Basophil activation test (BAT)
- Oral food challenge (OFC)
-
Birmingham, United Kingdom
- +10 more
Aug 16, 2022
Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- Best-Available Therapy(BAT) Regimen
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Oct 10, 2023
Brown Adipose Tissue Activity in Response to Semaglutide
Not yet recruiting
- Obesity
- Semaglutide Injectable Product
- (no location specified)
Jan 17, 2023
Obesity Trial in Saint Louis (Cold exposure, Exposure to thermoneutral conditions)
Completed
- Obesity
- Cold exposure
- Exposure to thermoneutral conditions
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Monitoring Allergen Immunotherapy in Allergic Rhinitis
Recruiting
- Immunotherapy
- +2 more
- A nasal fluid Basophil Activation Test (BAT)
-
Arnhem, NetherlandsRijnstate Hospital
Nov 10, 2022
Music Performance Anxiety Trial in Würzburg (Virtual Reality Exposure Therapy (VRET), Progressive Muscle Relaxation (PMR))
Recruiting
- Music Performance Anxiety
- Virtual Reality Exposure Therapy (VRET)
- Progressive Muscle Relaxation (PMR)
-
Würzburg, GermanyDepartment of Psychiatry, Psychosomatics, and Psychotherapy, Cen
Feb 9, 2023
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022
Brown Adipose Tissue Trial in Basel (Glyceroltrinitrat)
Not yet recruiting
- Brown Adipose Tissue
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Department of Endocrinology
Jan 24, 2023
Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)
Not yet recruiting
- Steroid-refractory Acute Graft-versus-host Disease
- MC0518
- BAT
- (no location specified)
Oct 4, 2023
Aging Trial in Orlando (Maximal oxygen consumption (V02 max), Brown adipose tissue (BAT) imaging, Muscle function testing)
Active, not recruiting
- Aging
- Maximal oxygen consumption (V02 max)
- +2 more
-
Orlando, FloridaTranslational Research Institute for Metabolism and Diabetes
Nov 16, 2022